ClinConnect ClinConnect Logo
Search / Trial NCT07067827

Self-questionnaire in Osteoporosis

Launched by CHU DE QUEBEC-UNIVERSITE LAVAL · Jul 7, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Osteoporosis, Self Administered Questionnaire, Family History, Rare Genetic Bone Diseases

ClinConnect Summary

This clinical trial is studying a special questionnaire designed to help identify people with osteoporosis who may have certain rare genetic bone diseases in their family. Osteoporosis is a condition where bones become weak and more likely to break, and family history can play an important role. The questionnaire asks about bone health issues in close family members to better understand risks and improve early detection and care.

Adults over 18 who have osteoporosis and are being treated at certain clinics in Quebec may be eligible to participate, as long as they have internet access and can complete the questionnaire themselves. Participants will be asked to fill out this self-questionnaire online, which focuses on signs and family history related to bone diseases. This study is not yet recruiting, but it hopes to make it easier to find people at higher risk and provide them with better, personalized care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult over 18
  • Followed by the rheumatology or endocrinology clinics at the CHUL (CHU de Quebec-Universite Laval)
  • Suffer from osteoporosis
  • Have internet access
  • Exclusion Criteria:
  • Unfit, unable to consent, unable to answer a questionnaire, unknown family history (e.g. adopted person)

About Chu De Quebec Universite Laval

CHU de Québec-Université Laval is a leading academic health center in Canada, renowned for its commitment to advancing medical research and improving patient care. As a prominent clinical trial sponsor, it leverages its extensive network of healthcare professionals, researchers, and state-of-the-art facilities to conduct innovative clinical studies across various therapeutic areas. With a strong emphasis on collaboration and ethical standards, CHU de Québec-Université Laval aims to translate scientific discoveries into effective treatments, enhancing health outcomes for diverse populations.

Locations

Quebec, , Canada

Patients applied

0 patients applied

Trial Officials

Laetitia Michou, MD PhD

Principal Investigator

CHU de Quebec-Universite Laval

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported